IL156794A0 - Chemical derivatives and their use as anti-telomerase agent - Google Patents

Chemical derivatives and their use as anti-telomerase agent

Info

Publication number
IL156794A0
IL156794A0 IL15679402A IL15679402A IL156794A0 IL 156794 A0 IL156794 A0 IL 156794A0 IL 15679402 A IL15679402 A IL 15679402A IL 15679402 A IL15679402 A IL 15679402A IL 156794 A0 IL156794 A0 IL 156794A0
Authority
IL
Israel
Prior art keywords
chemical derivatives
telomerase agent
telomerase
agent
derivatives
Prior art date
Application number
IL15679402A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL156794A0 publication Critical patent/IL156794A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15679402A 2001-01-09 2002-01-09 Chemical derivatives and their use as anti-telomerase agent IL156794A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100205A FR2819255B1 (fr) 2001-01-09 2001-01-09 Derives chimiques et leur application comme agent antitelomerase
PCT/FR2002/000057 WO2002055515A1 (fr) 2001-01-09 2002-01-09 Derives chimiques et leur application comme agent antitelomerase

Publications (1)

Publication Number Publication Date
IL156794A0 true IL156794A0 (en) 2004-02-08

Family

ID=8858610

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15679402A IL156794A0 (en) 2001-01-09 2002-01-09 Chemical derivatives and their use as anti-telomerase agent

Country Status (8)

Country Link
EP (1) EP1351957A1 (fr)
JP (1) JP2004520350A (fr)
AU (1) AU2002229859B2 (fr)
CA (1) CA2433723A1 (fr)
FR (1) FR2819255B1 (fr)
IL (1) IL156794A0 (fr)
MX (1) MXPA03005975A (fr)
WO (1) WO2002055515A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887873B2 (en) 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
FR2850970B1 (fr) * 2003-02-07 2006-07-07 Aventis Pharma Sa Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
US5767278A (en) * 1995-10-06 1998-06-16 Geron Corporation Telomerase inhibitors
JPH1160573A (ja) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd トリアジン誘導体及びテロメラーゼ阻害剤

Also Published As

Publication number Publication date
MXPA03005975A (es) 2005-02-14
WO2002055515A1 (fr) 2002-07-18
FR2819255A1 (fr) 2002-07-12
AU2002229859B2 (en) 2008-03-13
EP1351957A1 (fr) 2003-10-15
JP2004520350A (ja) 2004-07-08
FR2819255B1 (fr) 2003-02-28
CA2433723A1 (fr) 2002-07-18

Similar Documents

Publication Publication Date Title
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AUPR879601A0 (en) Novel chemical compounds and their use
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
ZA200300545B (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents.
IL150701A0 (en) 4-aminopicolinates and their use as herbicides
AU8729901A (en) Benzoylpyrazols and their use as herbicides
AU2002358700A8 (en) Urea derivatives as vr1- antagonists
AU2002314252A1 (en) Chemical derivatives and the use thereof as an anti-telomerase agent
HUP0402025A3 (en) Novel bensophenone derivatives or salts thereof and their use
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002251140A1 (en) Chemical derivatives and their use as anti-telomerase agent
GB0126889D0 (en) Compounds and their uses
AUPR879701A0 (en) Novel chemical compounds and their use
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
EP1392317A4 (fr) 1-benzazepines substituees et leurs derives
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent
AU2001282268A1 (en) Phenantridine derivatives and their use as anti-telomerase agent
EP1367123A4 (fr) Neurotonine et utilisation
GB0122162D0 (en) Agent
GB0106987D0 (en) Immunotherapeuitic agent